Underweight on Pharma stocks
Ravi Dharamshi of ValueQuest Investment Advisors disclosed that his Fund is underweight Pharma stocks because their growth prospects are subdued. He explained that the sector was a beneficiary of a short term boom cycle...
Avoid investing in Pharma & IT stocks. They are now out of favour: Ravi Dharamshi
Subscribe To Our Free Newsletter |